118 related articles for article (PubMed ID: 357235)
1. Transient thrombocytopenia in a child on sodium valproate.
Cole AP
Dev Med Child Neurol; 1978 Aug; 20(4):487-90. PubMed ID: 357235
[No Abstract] [Full Text] [Related]
2. Sodium valproate and thrombocytopenia.
Hoffman LM
Can Med Assoc J; 1982 Feb; 126(4):358-9. PubMed ID: 6802479
[No Abstract] [Full Text] [Related]
3. Thrombocytopenia associated with sodium valproate treatment.
Neophytides AN; Nutt JG; Lodish JR
Ann Neurol; 1979 Apr; 5(4):389-90. PubMed ID: 375808
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid and thrombocytopenia. Case report.
Patel CC; Church S; Reilly KM
J Ky Med Assoc; 1982 Apr; 80(4):213-5. PubMed ID: 6808068
[No Abstract] [Full Text] [Related]
5. Haematological disturbances during long-term valproate therapy.
Brichard B; Vermylen C; Scheiff JM; Ninane J; Cornu G
Eur J Pediatr; 1994 May; 153(5):378-80. PubMed ID: 8033931
[TBL] [Abstract][Full Text] [Related]
6. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
Lackmann GM
Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
[TBL] [Abstract][Full Text] [Related]
7. Sodium valproate and thrombocytopenia.
Winfield DA; Benton P; Espir ML; Arthur LJ
Br Med J; 1976 Oct; 2(6042):981. PubMed ID: 788857
[No Abstract] [Full Text] [Related]
8. [A case of thrombocytopenia with antiplatelet autoantibody after sodium valproate administration--with statistical analysis of 33 cases administrated sodium valproate].
Terui T; Ktda K; Mitani T; Terada S; Kure T; Takamura H; Hirayama M; Niitsu Y; Nakazawa O
Rinsho Ketsueki; 1987 Jun; 28(6):865-71. PubMed ID: 3118077
[No Abstract] [Full Text] [Related]
9. Sodium valproate and thrombocytopenia.
Miyake S; Honda K; Kimura S; Ike Y
Brain Dev; 1979; 1(4):319-22. PubMed ID: 121951
[TBL] [Abstract][Full Text] [Related]
10. Sodium valproate and platelet-count.
Raworth RE; Birchall G
Lancet; 1978 Mar; 1(8065):670-1. PubMed ID: 76214
[No Abstract] [Full Text] [Related]
11. IgM platelet autoantibody due to sodium valproate.
Sandler RM; Emberson C; Roberts GE; Voak D; Darnborough J; Heeley AF
Br Med J; 1978 Dec; 2(6153):1683-4. PubMed ID: 367512
[No Abstract] [Full Text] [Related]
12. Fatal pulmonary hemorrhage during high-dose valproate monotherapy.
Sleiman C; Raffy O; Roué C; Mal H
Chest; 2000 Feb; 117(2):613. PubMed ID: 10669721
[No Abstract] [Full Text] [Related]
13. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study.
Koenig S; Gerstner T; Keller A; Teich M; Longin E; Dempfle CE
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):375-82. PubMed ID: 18600085
[TBL] [Abstract][Full Text] [Related]
14. Sodium valproate and haemostasis--what to do.
Drug Ther Bull; 1984 Mar; 22(6):23-4. PubMed ID: 6425029
[No Abstract] [Full Text] [Related]
15. [Sodium valproate, platelet dysfunction and bleeding (author's transl)].
Loiseau P
Nouv Presse Med; 1981 Dec; 10(46):3789-90. PubMed ID: 6798554
[TBL] [Abstract][Full Text] [Related]
16. The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data.
Buoli M; Serati M; Botturi A; Altamura AC
Drugs R D; 2018 Mar; 18(1):1-5. PubMed ID: 29260458
[TBL] [Abstract][Full Text] [Related]
17. Sodium valproate and platelet counts.
Eastham RD; Jancar J
Br Med J; 1980 Jan; 280(6208):186. PubMed ID: 6766772
[No Abstract] [Full Text] [Related]
18. Absence status and the concurrent administration of clonazepam and valproate sodium.
Watson B
Am J Hosp Pharm; 1979 Jul; 36(7):887. PubMed ID: 112862
[No Abstract] [Full Text] [Related]
19. [Clinical irrelevance of the hematologic side effects of sodium valproate (Depakine)].
Loisseau P; Martínez-Lage JM
Rev Med Univ Navarra; 1981 Sep; 25(3):14-6. PubMed ID: 6803320
[No Abstract] [Full Text] [Related]
20. Comparative efficacy and safety of intravenous valproate and phenytoin in children.
Rai A; Aggarwal A; Mittal H; Sharma S
Pediatr Neurol; 2011 Nov; 45(5):300-4. PubMed ID: 22000309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
